# 8-K filed: 4D Molecular Therapeutics, Inc.

> sec 8k · VERIFIED · 2026-06-29

Filed: 2026-06-29 AccNo: 0001193125-26-286880 Size: 141 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

- Company: 4D Molecular Therapeutics, Inc.
- Sector: biotech
- Primary source: https://www.sec.gov/Archives/edgar/data/1650648/000119312526286880/0001193125-26-286880-index.htm

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.